Xarelto Resources & Sample Request
PBS Information: Authority Required (STREAMLINED). Refer to PBS Schedule for full authority information.
PLEASE REVIEW THE FULL PRODUCT INFORMATION (PI) BEFORE PRESCRIBING. APPROVED PI AVAILABLE HERE
This page contains information and resources for Xarelto. You can order your free resources and sample packs via the button below or scrolling further down this page.
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
With independent commentary from Dr Scott Dunkley
Hear from Professor Craig I Coleman from the University of Connecticut as he speaks with Professor John Camm on his recent study into rivaroxaban with relation to diabetes mellitus. Download the slides from this presentation.
In the series of video resources below, Professor Keith Fox discusses the challenges and opportunities of atrial fibrillation and renal impairment in this six part Q&A video series.
Below, Professor Keith Fox discusses the challenges and opportunities of atrial fibrillation and renal impairment. For your convenience, his interview is divided into small snippets of Q&A. Below is Part One:
Download soft copies of the PDF resources available for Xarelto:
Order resources and sample packs
Complete the form below to request free resources (hard copies) and sample packs.
Bayer Australia Ltd. ABN 22 000 138 714, 875 Pacific Highway, Pymble NSW 2073.Xarelto® is a registered trademark of Bayer Group, Germany. Updated Feb 2022. PP-XAR-AU-